ID: ALA4159982

Max Phase: Preclinical

Molecular Formula: C21H23NO2S

Molecular Weight: 353.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOCc1cnc2ccc(OCc3ccccc3)cc2c1SCC

Standard InChI:  InChI=1S/C21H23NO2S/c1-3-23-15-17-13-22-20-11-10-18(12-19(20)21(17)25-4-2)24-14-16-8-6-5-7-9-16/h5-13H,3-4,14-15H2,1-2H3

Standard InChI Key:  NIUHYVMDRWBKEX-UHFFFAOYSA-N

Associated Targets(Human)

Peptide N-myristoyltransferase 1 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Peptide N-myristoyltransferase 2 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glycylpeptide N-tetradecanoyltransferase 128 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 353.49Molecular Weight (Monoisotopic): 353.1449AlogP: 5.46#Rotatable Bonds: 8
Polar Surface Area: 31.35Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.30CX LogP: 4.81CX LogD: 4.81
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.50Np Likeness Score: -1.00

References

1. Goncalves V, Brannigan JA, Laporte A, Bell AS, Roberts SM, Wilkinson AJ, Leatherbarrow RJ, Tate EW..  (2017)  Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase.,  (1): [PMID:28626547] [10.1039/C6MD00531D]

Source